Skip to content

Alkermes ALKS Total Liabilities

Total Liabilities at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$66.37B-11.5%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$659.02M+21.3%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$2.96B+26.6%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$1.5B+30.1%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
LQD
Liquidia CorporationLQDA

Other financials

Income statement

See full
Revenue$392.9M+28.2%
Gross profit$331.3M+28.8%
Operating income-$48.3M-450%
Net income-$66.5M-396%
EPS (diluted)-$0.40-408%

Balance sheet

See full
Cash & equivalents$351.6M-12.1%
Total debt$1.6B+2,034%
Total equity$1.8B+15.9%
Total assets$4.3B+105%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$4.1M-59.5%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$7.5B+9.7%
Enterprise value$8.73B+41.2%
P/E49.1×+29.7×
P/S4.8×+0.3×

Profitability

See full
Gross margin86.6%+2.2pp
Operating margin12.3%-13.6pp
Net margin9.8%-13.5pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity9.4%-16.1pp
Debt / equity0.9×+0.9×
Current ratio2.3×-1.1×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Alkermes’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alkermes's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alkermes's total liabilities?
Alkermes (ALKS) reported total liabilities of $2.51B in Q1 2026.
How has Alkermes's total liabilities changed year-over-year?
Alkermes's total liabilities increased by 339.4% year-over-year, from $570.39M to $2.51B.
What is the long-term trend for Alkermes's total liabilities?
Over 5 years (2020 to 2025), Alkermes's total liabilities has grown at a -5.4% compound annual growth rate (CAGR), from $882.75M to $667.7M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.